Taking into consideration that the induction of hemopoiesis through the increase of endogenous EPO leads to anisocytosis (and by extension to an increase in RDW), it is possible that these observations suggest the stimulation of hemopoiesis from dapagliflozin in patients with HF and DM. Here, EPO is linked to diabetes mellitus.